Experts Highlight Advances in Lung Cancer Pathology During World Conference Closing Plenary Session
Krithika Subramanian, PhDDrs. Keith Kerr and Sanja Dacic shared findings from the IASLC Pathology Committee, which is investigating how to best assess pathologic response to neoadjuvant immunotherapy in lung cancer. Read more
Data Show Certain Reproductive Factors Are Associated with Increased Risk of Lung Cancer in Women
Fred GebhartDuring WCLC 2023, Dr. Yan Zhang presented findings that she says support the inclusion of factors such as early menarche and early menopause in lung cancer screening programs. Read more
WCLC Plenary Session Featured Lectureship Award Winners Discussing Range of Issues in Thoracic Oncology
Darcy LewisDrs. Wendy Cooper, Melissa Culligan, And Navneet Singh concluded the session with talks on the future of pathology, enhancing the patient experience, and accurate staging in lung cancer. Read more
Middle East and Africa Region Earns Bragging Rights with Most Points During 2023 Wellness Challenge
Erin JungmeyerThe challenge, Step It Up for Research, helped WCLC 23 attendees stay active during the meeting while raising money to support the IASLC Foundation, which provides grants for research, education, and other scientific initiatives. Read more
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
Darcy LewisIASLC Staging and Prognostic Factors Committee Chair Dr. Hisao Asamura and Drs. Valerie Rusch and Enrico Ruffini summarized the data and recommendations in lung cancer, mesothelioma, and thymic cancer. Read more
AEGEAN Shows Benefit with the Addition of Perioperative Durvalumab to Neoadjuvant Chemotherapy in Resectable NSCLC
Fred GebhartDr. Tetsuya Mitsudomi, who presented the data at WCLC 2023, said regardless of disease stage, the addition of perioperative durvalumab did not adversely impact the feasibility, type, approach, or timing of surgery for participants in the trial. Read more
World Conference Plenary Addresses Barriers to—and Opportunities for—Lung Cancer Care in Low- to Middle-Income Countries
Jennifer Cable, PhDDrs. Mariam Jamal-Hanjani, Alan Sihoe, Anil Tibdewal, and Ross Soo discussed challenges and strategies across the lung cancer spectrum—from early-stage to oligometastatic and advanced disease. Read more
Lectureship Award Winners Discuss Broad Thoracic Oncology Topics During WCLC 23 Plenary Session
Darcy LewisHonorees Drs. Jessica Donington, Rafal Dziadziuszko, and Jie Wang presented thought-provoking talks on return to treatment after surgery, radiation oncology in Poland, and biomarkers in small cell lung cancer. Read more
The IASLC Academy’s 2023 cohort spent months leading up to WCLC 2023 crafting case summaries in hopes of winning a spot in the association’s first case-based simulation course. Read more